CHUSX
Price
$30.78
Change
+$0.06 (+0.20%)
Updated
Sep 26 closing price
Net Assets
21.92M
RNPEX
Price
$71.60
Change
+$0.37 (+0.52%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

CHUSX vs RNPEX

Header iconCHUSX vs RNPEX Comparison
Open Charts CHUSX vs RNPEXBanner chart's image
Alger Global Equity A
Price$30.78
Change+$0.06 (+0.20%)
VolumeN/A
Net Assets21.92M
American Funds New Perspective R4
Price$71.60
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets161.39B
CHUSX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CHUSX vs. RNPEX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHUSX is a Buy and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 161B vs. CHUSX (21.9M). RNPEX pays higher dividends than CHUSX: RNPEX (0.48) vs CHUSX (0.00). CHUSX was incepted earlier than RNPEX: CHUSX (22 years) vs RNPEX (23 years). CHUSX (2.54) is less costly to investors than RNPEX (0.76). CHUSX is a more actively managed with annual turnover of: 93.65 vs. RNPEX (24.00). RNPEX has a lower initial minimum investment than CHUSX: RNPEX (250) vs CHUSX (1000). RNPEX annual gain was more profitable for investors over the last year : 10.73 vs. CHUSX (-5.09). RNPEX return over 5 years is better than : 40.31 vs. CHUSX (16.81).
CHUSXRNPEXCHUSX / RNPEX
Total Expense Ratio1.200.76158%
Annual Report Gross Expense Ratio2.540.76334%
Fund Existence22 years23 years-
Gain YTD10.36217.55059%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets21.9M161B0%
Annual Yield % from dividends0.000.48-
Returns for 1 year-5.0910.73-47%
Returns for 3 years49.6461.3681%
Returns for 5 years16.8140.3142%
Returns for 10 years76.43110.4869%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.900.06
+2.11%
CytomX Therapeutics
SOLV71.370.91
+1.29%
Solventum Corp
EFSC58.840.22
+0.38%
Enterprise Financial Services Corp
WSBK9.560.03
+0.31%
Winchester Bancorp Inc
SPHL0.46-0.01
-2.28%
Springview Holdings Ltd